Gene-environment interactions in inflammatory bowel disease pathogenesis

Current Opinion in Gastroenterology

Volumn 31, Issue 4, 2015, Pages 277-282

  Wang, Ming Hsi ^a   Achkar, Jean Paul ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Exposome; Gene environmental interactions; Gut microbiota; Inflammatory bowel disease; Logic regression

Indexed keywords

ARTICLE; ENVIRONMENTAL FACTOR; EVALUATION STUDY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HERITABILITY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIOME; PATHOGENESIS; SMOKING; ADVERSE EFFECTS; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; METHODOLOGY; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

GASTROINTESTINAL TRACT; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; RESEARCH DESIGN; SMOKING;

EID: 84942565591     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000188     Document Type: Article

References (55)

1. Rogler G, Vavricka S. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis 2015;21:400-408. A comprehensive overview of the impact of environmenal exposure in IBD.
2. Fiocchi C. Integrating omics: the future of IBD? Dig Dis 2014;32(Suppl 1):96-102. An excellent overview of a paradigm-shifting concept of how to approach an IBD using cutting-edge omics-based multisystem information.
3. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.
4. Orholm M, Binder V, Sorensen TI, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-1081.
5. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999;94:2918-2922.
6. Pinsk V, Lemberg DA, Grewal K, et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007;102:1077-1083.
7. Tsironi E, Feakins RM, Probert CS, et al. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004;99:1749-1755.
8. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
9. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920.
10. Eder W, Ege MJ, Von Mutius E. The asthma epidemic. N Engl J Med 2006;355:2226-2235.
11. Myles IA. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J 2014;13:61.
12. Amre DK, D'Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007;102:2016-2025.
13. Chapman-Kiddell CA, Davies PS, Gillen L, Radford-Smith GL. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 2010;16:137-151.
14. Borrelli O, Cordischi L, Cirulli M, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006;4:744-753.
15. Fiocchi C. Genes and 'in-vironment': how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Dig Dis 2012;30(Suppl 3):2-11.
16. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA 2012;109:1193-1198.
17. Hasler R, Feng Z, Backdahl L, et al. A functional methylome map of ulcerative colitis. Genome Res 2012;22:2130-2137.
18. Quigley EM. Epigenetics: filling in the 'heritability gap' and identifying geneenvironment interactions in ulcerative colitis. Genome Med 2012;4:72.
19. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004;10:848-859.
20. Timmer A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis 2003;21:91-104.
21. Helbig KL, Nothnagel M, Hampe J, et al. A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology. BMC Med Genet 2012;13:14.
22. Ananthakrishnan AN, Nguyen DD, Sauk J, et al. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm Bowel Dis 2014;20:783-789. One of the few well-demonstrated examples of G-E interaction in IBD.
23. Ruczinski I, Kooperberg C, Le Blanc ML. Logic regression. J Comput Graph Statis 2003;12:475-511.
24. Ruczinski I, Kooperberg C, Le Blanc ML. Exploring interactions in high-dimensional genomic data: an overview of logic regression, with applications. J Multivar Anal 2004;90:178-195.
25. Wang MH, Fiocchi C, Zhu X, et al. Gene-gene and gene-environment interactions in ulcerative colitis. Hum Genet 2014;133:547-558. A pinoeering study applying a novel and creative data-mining method on large GWAS data to identify high-order G-G and G-E interactions and validated in an independent dataset.
26. Sung HY, Francis SE, Crossman DC, Kiss-Toth E. Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific. Immunol Lett 2006;104:171-177.
27. Wang MH, Fiocchi C, Ripke S, et al. A model integrating genetic and environmental factors interactions can predict Crohn's disease risk [abstract]. Am J Gastroenterol 2014;(Supplement 109):S503.
28. Ito K, Lim S, Caramori G, et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001;15:1110-1112.
29. Benson AK, Kelly SA, Legge R, et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA 2010;107:18933-18938.
30. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009;1:6ra14.
31. Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol 2013;48:315-321.
32. Bushman FD, Lewis JD, Wu GD. Diet, gut enterotypes and health: is there a link? Nestle Nutr Inst Workshop Ser 2013;77:65-73.
33. Wu GD, Bushmanc FD, Lewis JD. Diet, the human gut microbiota, and IBD. Anaerobe 2013;24:117-120.
34. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008;263:597-606.
35. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-323.
36. Edwards CM, George BD, Jewell DP, et al. Role of a defunctioning stoma in the management of large bowel Crohn's disease. Br J Surg 2000;87:1063-1066.
37. Satokari R. Contentious host-microbiota relationship in inflammatory bowel disease: can foes become friends again? Scand J Gastroenterol 2015;50:34-42.
38. Haberman Y, Tickle TL, Dexheimer PJ, et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 2015;125:1363. A comprehensive report combining clinical, genetic, and high-throughput mucosal transcriptomic and microbial community profiling at the time of diagnosis. The study may redirect prognostic and therapeutic approaches in IBD.
39. Lipinski S, Till A, Sina C, et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J Cell Sci 2009;122:3522-3530.
40. Thomas D. Gene: environment-wide association studies-emerging approaches. Nat Rev Genet 2010;11:259-272.
41. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health 2010;31:21-36.
42. Fridley BL, Biernacka JM. Gene set analysis of SNP data: benefits, challenges, and future directions. Eur J Hum Genet 2011;19:837-843.
43. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004;75:353-362.
44. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: a review of statistical methods and recommendations for their application. Am J Hum Genet 2010;86:6-22.
45. Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007;31:383-395.
46. Wei S, Wang LE, McHugh MK, et al. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis 2012;33:1531-1537.
47. Kooperberg C, Ruczinski I. Identifying interacting SNPs using Monte Carlo logic regression. Genet Epidemiol 2005;28:157-170.
48. Wang MH, Fiocchi C, Ripke S, et al. A novel approach to detect cumulative genetic effects and genetic interactions in Crohn's disease. Inflamm Bowel Dis 2013;19:1799-1808.
49. Breiman L. Random forests. Mach Learn 2001;45:5-32.
50. Maenner MJ, Denlinger LC, Langton A, et al. Detecting gene-by-smoking interactions in a genome-wide association study of early-onset coronary heart disease using random forests. BMC Proc 2009;3(Suppl 7):S88.
51. Zhai R, Zhao Y, Liu G, et al. Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study. Cancer 2012;118:804-811.
52. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-147.
53. Okazaki T, Wang MH, Rawsthorne P, et al. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based casecontrol study: evidence of gene-gene interactions. Inflamm Bowel Dis 2008;14:1528-1541.
54. Yang C, Xu Y, Sun N, et al. The combined effects of the BDNF and GSK3B genes modulate the relationship between negative life events and major depressive disorder. Brain Res 2010;1355:1-6.
55. Polytarchou C, Koukos G, Iliopoulos D. Systems biology in inflammatory bowel diseases: ready for prime time. Curr Opin Gastroenterol 2014;30:339-346. A critical overview of the impact of using large 'omes' data generated by highthroughput technology and system biology-based approach for delivery of healthcare in IBD.